-
Je něco špatně v tomto záznamu ?
Současný pohled na koenzym Q
[Recent view of coenzyme Q]
Hana Rauchová, Martina Vokurková
Jazyk čeština Země Česko
- MeSH
- antioxidancia terapeutické užití MeSH
- energetický metabolismus fyziologie účinky léků MeSH
- financování organizované MeSH
- klinické zkoušky jako téma využití MeSH
- lékové interakce fyziologie MeSH
- lidé MeSH
- medicína založená na důkazech trendy MeSH
- mitochondrie fyziologie chemie metabolismus MeSH
- nežádoucí účinky léčiv metabolismus MeSH
- oxidace-redukce MeSH
- oxidancia izolace a purifikace MeSH
- potravní doplňky využití MeSH
- ubichinon dějiny izolace a purifikace terapeutické užití MeSH
- Check Tag
- lidé MeSH
Coenzyme Q (CoQ), a lipophilic substituted benzoquinone present in all cells. Besides its fundamental role of an electron carrier associated with energy production in the respiratory chain, CoQ has two other functions in mitochondria. It is an essential factor in activation of protein uncoupling and it controls permeability of transition pores. Moreover, it participates in extramitochondrial electron transport in plasma membranes and lysosomes, controls physicochemical properties of membranes, and is the only endogenous lipid antioxidant. Its pro-oxidant role consists in generating the major superoxide radical/H2O2 secondmessenger system. Biosynthesis of CoQ proceeds in every cell, small amounts of CoQ can be obtained from diet. CoQ is also available as a dietary supplement. It shows minimal toxicity, excellent tolerance, and no significant side effects. Its beneficial effects are largely attributed to its essential role in cellular bioenergetics and antioxidant properties. Supplementation of CoQ can improve conditions of a wide range of pathological states. Some forms of mitochondrial CoQ deficiency respond well to its oral administration. Recent meta-analysis of tests for hypertension is also promising. This review summarizes the current knowledge of the therapeutic efficacy of CoQ in various diseases.
Recent view of coenzyme Q
Lit.: 94
- 000
- 00000naa 2200000 a 4500
- 001
- bmc09004335
- 003
- CZ-PrNML
- 005
- 20111210153823.0
- 008
- 091201s2009 xr e cze||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Rauchová, Hana, $d 1950- $7 xx0074209
- 245 10
- $a Současný pohled na koenzym Q / $c Hana Rauchová, Martina Vokurková
- 246 11
- $a Recent view of coenzyme Q
- 314 __
- $a Fyziologický ústav AV ČR v.v.i. a Centra výzkumu chorob srdce a cév, Praha 4
- 504 __
- $a Lit.: 94
- 520 9_
- $a Coenzyme Q (CoQ), a lipophilic substituted benzoquinone present in all cells. Besides its fundamental role of an electron carrier associated with energy production in the respiratory chain, CoQ has two other functions in mitochondria. It is an essential factor in activation of protein uncoupling and it controls permeability of transition pores. Moreover, it participates in extramitochondrial electron transport in plasma membranes and lysosomes, controls physicochemical properties of membranes, and is the only endogenous lipid antioxidant. Its pro-oxidant role consists in generating the major superoxide radical/H2O2 secondmessenger system. Biosynthesis of CoQ proceeds in every cell, small amounts of CoQ can be obtained from diet. CoQ is also available as a dietary supplement. It shows minimal toxicity, excellent tolerance, and no significant side effects. Its beneficial effects are largely attributed to its essential role in cellular bioenergetics and antioxidant properties. Supplementation of CoQ can improve conditions of a wide range of pathological states. Some forms of mitochondrial CoQ deficiency respond well to its oral administration. Recent meta-analysis of tests for hypertension is also promising. This review summarizes the current knowledge of the therapeutic efficacy of CoQ in various diseases.
- 650 _2
- $a ubichinon $x dějiny $x izolace a purifikace $x terapeutické užití $7 D014451
- 650 _2
- $a mitochondrie $x fyziologie $x chemie $x metabolismus $7 D008928
- 650 _2
- $a energetický metabolismus $x fyziologie $x účinky léků $7 D004734
- 650 _2
- $a antioxidancia $x terapeutické užití $7 D000975
- 650 _2
- $a oxidancia $x izolace a purifikace $7 D016877
- 650 _2
- $a potravní doplňky $x využití $7 D019587
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a medicína založená na důkazech $x trendy $7 D019317
- 650 _2
- $a nežádoucí účinky léčiv $x metabolismus $7 D064420
- 650 _2
- $a lékové interakce $x fyziologie $7 D004347
- 650 _2
- $a klinické zkoušky jako téma $x využití $7 D002986
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a lidé $7 D006801
- 700 1_
- $a Vokurková, Martina, $d 1973- $7 xx0037678
- 773 0_
- $w MED00011010 $t Chemické listy $g Roč. 103, č. 1 (2009), s. 32-39 $x 0009-2770
- 856 41
- $u http://chemicke-listy.cz/docs/full/2009_01_32-39.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 1918 $c 395 $y 9
- 990 __
- $a 20091201083418 $b ABA008
- 991 __
- $a 20091201132544 $b ABA008
- 999 __
- $a ok $b bmc $g 700153 $s 562565
- BAS __
- $a 3
- BMC __
- $a 2009 $b 103 $c 1 $d 32-39 $i 0009-2770 $m Chemické listy $x MED00011010
- LZP __
- $a 2009-63/vtal